Products

To address key scientific issues, genOway designs, develops and markets proprietary innovative genetically modified models. These models are called products. The products target the two main issues in bio-pharmaceutical R&D: predictability and development time, in three fields: gene validation, drug screening and pharmacological - toxicological studies.

Our products have the following characteristics:

	A product targets a scientific question of broad interest for therapeutic areas.
	A product is validated by leading academic laboratories and companies to provide the scientist customer with a clear understanding of the strengths and limits of the products.

The first range of five products will help analyze the contribution of immunological causes in human disease such as oncology, metabolic disorders … Partnerships with laboratories to validate these models will be implemented in early 2003. The products will be available to our partners in 2003.
Other products already under development are targeting other therapeutic areas. Collaboration should start in late 2003. Complementary information will be released in mid 2003.